Profusa, Inc.

16 articles about Profusa, Inc.

• Profusa and Partners Announce Initiation of Study to Measure Early Signs of Influenza Through Biosensor Technology

  3/3/2020

  DARPA-Backed Study Leverages Profusa's Lumee® Oxygen Platform as Part of a Larger Effort to Speed Detection and Predict Disease Outbreaks

• 

  BioSpace Movers and Shakers: April 12

  4/12/2019

  Biopharma companies tap new hires to assume roles in leadership positions, with additions at Metrion, JDRF, Ribometrix, and more.

• Profusa Expands Leadership Team with Digital Health, Government and Business Development Hires

  4/11/2019

  Profusa, an empowered health company that is pioneering the next generation of personalized medicine, has expanded its leadership team to further the company's ability to transform the health and well-being of patients worldwide.

• NextFlex and Profusa Unveil Skin-worn Reader Prototype for Continuous Oxygen Monitoring at FLEX 2019

  2/18/2019

  Reader that works with hydrogel sensor injected under the skin developed in only four months at NextFlex facility in San Jose

• Profusa Named One of FierceMedTech's "Fierce 15" Companies To Watch

  2/15/2019

  Award recognizes Profusa's innovative injectable biosensor that monitors health in real-time

• Profusa Recognized by Frost & Sullivan For Innovation in the Biochemical Sensors Market

  10/15/2018

  Profusa, today announced it has been awarded Entrepreneurial Company of the Year in the Continuous Monitoring Biochemical Sensors Industry by Frost & Sullivan.

• Profusa Closes $45 Million Series C Financing

  8/14/2018

  Leading global investors join this round; financing will accelerate commercialization of Lumee™ Oxygen Platform and pioneering glucose biosensors

• Injectable Body Sensors Take Personal Chemistry to a Cell Phone Closer to Reality

  3/19/2018

  Scientists are presenting results showing tiny biosensors that become one with the body have overcome this barrier, and stream data to a mobile phone and to the cloud for personal and medical use.

• Former Senate Majority Leader William Frist, M.D., Joins Profusa's Board

  6/7/2017

• Profusa And North Carolina State University's ASSIST Center Awarded $1.5M NIH Grant To Co-Develop Ultrathin, Wearable, Wireless, Oxygen Monitor For Patients With Peripheral Artery Disease

  2/6/2017

• Profusa Receives CE Mark To Market The Lumee Oxygen Platform For Continuous, Real-Time Monitoring Of Tissue Oxygen

  10/3/2016

• Profusa Awarded $7.5M DARPA Grant To Develop Tissue-Integrated Biosensors For Continuous Monitoring Of Multiple Body Chemistries

  7/12/2016

• Profusa Debuts Tissue-Integrated Sensors For Long-Term Continuous Monitoring Of Body Chemistry At The Pioneers Festival In Vienna

  5/25/2016

• Profusa To Showcase Tissue-Integrated Sensors For Long-Term Continuous Monitoring Of Body Chemistry At The Pioneers Festival In Vienna

  5/16/2016

• Profusa Wins Silver At 2016 Edison Awards

  4/22/2016

• Profusa Names Bradley W. Rice, Ph.D., Vice President Of Engineering R&D

  4/18/2016